Gemini Therapeutics, Inc. Appoints Samuel Barone as Chief Medical Officer
April 12, 2021 at 01:00 pm
Gemini Therapeutics, Inc. announced the appointment of Samuel Barone, M.D., as the company’s Chief Medical Officer, effective immediately. Barone joins the company after most recently serving as co-Founder, Manager and Chief Medical Officer of Halodine, LLC. Prior, he held the role of Chief Medical Officer of Veloce BioPharma. Barone previously served as Senior Vice President at Adverum Biotechnologies. While at Avalanche Biotechnologies, Barone served as Chief Medical Officer. Before joining Avalanche Biotechnologies, Barone served as a Medical Officer in the Office of Cellular, Tissue and Gene Therapies at the U.S. Food and Drug Administration (FDA).